# Massachusetts Healthcare Marketing Compliance Rules - BORM and AG

Massachusetts Board of Registration in Medicine advertising rules at 243 CMR 2.07, Chapter 93A consumer protection enforcement, and the AG-led oversight that shapes MA healthcare marketing exposure.

Canonical page: https://regencompliance.ai/state/massachusetts


## Overview

Massachusetts healthcare marketing compliance operates under the Board of Registration in Medicine (BORM), which enforces 243 CMR 2.07 advertising rules, and the Massachusetts AG's Chapter 93A authority. Chapter 93A is unusually broad and provides treble damages plus attorney fees, which makes Massachusetts a meaningful private-litigation jurisdiction for healthcare marketing in addition to AG enforcement.


## Massachusetts Board of Registration in Medicine (BORM)

BORM enforces 243 CMR 2.07, which restricts deceptive advertising, regulates testimonial use, requires substantiation for outcome claims, and limits guarantee language. Massachusetts has also been active on physician-owned corporate-entity marketing and on supervision representations in aesthetic practice.


## State attorney general focus

The MA AG uses Chapter 93A authority - one of the broadest consumer protection statutes in the country - against deceptive healthcare marketing. Recent enforcement has included telehealth prescribing advertising, compounded medication marketing, and cosmetic practice pricing. Chapter 93A also permits private actions with treble damages and fees, creating significant class-action exposure.


## Focus areas

- **Chapter 93A private enforcement**: Chapter 93A is the most plaintiff-friendly consumer protection statute in the US. Healthcare marketing that misleads consumers can face class actions with treble damages even where AG enforcement does not act.
- **Testimonial and substantiation rules**: BORM 243 CMR 2.07 has specific rules on testimonial use and on substantiation for outcome claims. Massachusetts has been active on aesthetic and weight-loss practice testimonials.
- **Compounded medication marketing**: Massachusetts has heightened sensitivity to compounding-pharmacy marketing following the NECC tragedy. AG enforcement on compounded GLP-1 and related medication marketing has been notably active.
- **Supervision representations**: BORM enforces supervision rules for non-physician practitioners in aesthetic settings. Marketing implying independent practice is treated as a substantive disciplinary matter.


## Patterns that draw enforcement attention

- **Outcome guarantees in any medical advertising**: BORM rules and Chapter 93A both create substantial exposure.
- **Compounded GLP-1 brand-equivalence claims**: MA AG has been active on compounded medication marketing under Chapter 93A.
- **Testimonials without substantiation or typical-experience disclosure**: BORM 243 CMR 2.07 substantiation rules.
- **Telehealth marketing minimizing clinical evaluation**: MA AG and BORM both have authority on this pattern.
- **Nurse-injector independence representations**: BORM supervision enforcement.


## Specialty notes

- Compounded medication clinics - heightened scrutiny post-NECC.
- Med spas - BORM supervision and substantiation rules.
- Weight loss / telehealth - active MA AG Chapter 93A focus.
- Aesthetic surgery - testimonial and guarantee rules.
- Dental - Massachusetts Board of Registration in Dentistry rules separate.


## Disclaimer

This summary reflects general patterns in Massachusetts healthcare marketing enforcement; it is not legal advice. For state-specific guidance on your practice, consult a Massachusetts-licensed healthcare marketing attorney.

---

RegenCompliance is FDA/FTC compliance scanning software for healthcare marketing, operated by Regen Portal LLC. Educational compliance tool, not legal advice. Not affiliated with the FDA or FTC. Contact: support@regencompliance.ai. Full site index for AI agents: https://regencompliance.ai/llms.txt